Institutional shares held 252 Million
729K calls
970K puts
Total value of holdings $32.4B
$93.8M calls
$125M puts
Market Cap $38.1B
296,040,992 Shares Out.
Institutional ownership 85.25%
# of Institutions 1,148


Latest Institutional Activity in A

Top Purchases

Q3 2024
Generation Investment Management LLP Shares Held: 3.03M ($390M)
Q3 2024
William Blair Investment Management, LLC Shares Held: 1.66M ($214M)
Q3 2024
Massachusetts Financial Services CO Shares Held: 15.6M ($2B)
Q3 2024
Worldquant Millennium Advisors LLC Shares Held: 333K ($42.8M)
Q3 2024
Balyasny Asset Management LLC Shares Held: 579K ($74.5M)

Top Sells

Q3 2024
Principal Financial Group Inc Shares Held: 384K ($49.4M)
Q3 2024
T. Rowe Price Investment Management, Inc. Shares Held: 8.24M ($1.06B)
Q3 2024
Harris Associates L P Shares Held: 1.12M ($144M)
Q3 2024
Citadel Advisors LLC Shares Held: 227K ($29.2M)
Q3 2024
Marshall Wace, LLP Shares Held: 212K ($27.3M)

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.


Insider Transactions at A

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
232K Shares
From 25 Insiders
Grant, award, or other acquisition 151K shares
Exercise of conversion of derivative security 76.9K shares
Bona fide gift 3.96K shares
Sell / Disposition
203K Shares
From 15 Insiders
Payment of exercise price or tax liability 4.09K shares
Open market or private sale 195K shares
Bona fide gift 3.96K shares

Track Institutional and Insider Activities on A

Follow AGILENT TECHNOLOGIES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells A shares.

Notify only if

Insider Trading

Get notified when an Agilent Technologies, Inc. insider buys or sells A shares.

Notify only if

News

Receive news related to AGILENT TECHNOLOGIES, INC.

Track Activities on A